ID   PYRG_ECOLI              Reviewed;         545 AA.
AC   P0A7E5; P08398; Q2MA52;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   15-MAR-2017, entry version 109.
DE   RecName: Full=CTP synthase {ECO:0000303|PubMed:11336655};
DE            EC=6.3.4.2 {ECO:0000269|PubMed:11336655, ECO:0000269|PubMed:4550559, ECO:0000269|PubMed:8385490};
DE   AltName: Full=Cytidine 5'-triphosphate synthase {ECO:0000303|PubMed:11336655};
DE   AltName: Full=Cytidine triphosphate synthetase {ECO:0000303|PubMed:15157079};
DE            Short=CTP synthetase {ECO:0000303|PubMed:3514618};
DE            Short=CTPS {ECO:0000303|PubMed:15157079};
DE   AltName: Full=UTP--ammonia ligase;
GN   Name=pyrG {ECO:0000303|PubMed:3514618};
GN   OrderedLocusNames=b2780, JW2751;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND DOMAIN.
RX   PubMed=3514618;
RA   Weng M., Makaroff C.A., Zalkin H.;
RT   "Nucleotide sequence of Escherichia coli pyrG encoding CTP
RT   synthetase.";
RL   J. Biol. Chem. 261:5568-5574(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-13.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded
RT   in the genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [5]
RP   CATALYTIC ACTIVITY, AND ENZYME REGULATION.
RX   PubMed=4550559; DOI=10.1021/bi00752a015;
RA   Levitzki A., Koshland D.E. Jr.;
RT   "Role of an allosteric effector. Guanosine triphosphate activation in
RT   cytosine triphosphate synthetase.";
RL   Biochemistry 11:241-246(1972).
RN   [6]
RP   SUBUNIT.
RX   PubMed=4550560; DOI=10.1021/bi00752a016;
RA   Levitzki A., Koshland D.E. Jr.;
RT   "Ligand-induced dimer-to-tetramer transformation in cytosine
RT   triphosphate synthetase.";
RL   Biochemistry 11:247-253(1972).
RN   [7]
RP   DOMAIN, AND MUTAGENESIS OF VAL-349; GLY-351 AND GLY-352.
RX   PubMed=3298209; DOI=10.1128/jb.169.7.3023-3028.1987;
RA   Weng M., Zalkin H.;
RT   "Structural role for a conserved region in the CTP synthetase
RT   glutamine amide transfer domain.";
RL   J. Bacteriol. 169:3023-3028(1987).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=8385490; DOI=10.1021/bi00065a032;
RA   Robertson J.G., Villafranca J.J.;
RT   "Characterization of metal ion activation and inhibition of CTP
RT   synthetase.";
RL   Biochemistry 32:3769-3777(1993).
RN   [9]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R.,
RA   Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME
RP   REGULATION, MUTAGENESIS OF CYS-379, AND ACTIVE SITE.
RX   PubMed=11336655; DOI=10.1042/0264-6021:3560223;
RA   Bearne S.L., Hekmat O., MacDonnell J.E.;
RT   "Inhibition of Escherichia coli CTP synthase by glutamate gamma-
RT   semialdehyde and the role of the allosteric effector GTP in glutamine
RT   hydrolysis.";
RL   Biochem. J. 356:223-232(2001).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS), FUNCTION, DOMAIN, AND ACTIVE
RP   SITE.
RX   PubMed=15157079; DOI=10.1021/bi0496945;
RA   Endrizzi J.A., Kim H., Anderson P.M., Baldwin E.P.;
RT   "Crystal structure of Escherichia coli cytidine triphosphate
RT   synthetase, a nucleotide-regulated glutamine amidotransferase/ATP-
RT   dependent amidoligase fusion protein and homologue of anticancer and
RT   antiparasitic drug targets.";
RL   Biochemistry 43:6447-6463(2004).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEX WITH ADP; CTP AND
RP   MAGNESIUM, AND ENZYME REGULATION.
RX   PubMed=16216072; DOI=10.1021/bi051282o;
RA   Endrizzi J.A., Kim H., Anderson P.M., Baldwin E.P.;
RT   "Mechanisms of product feedback regulation and drug resistance in
RT   cytidine triphosphate synthetases from the structure of a CTP-
RT   inhibited complex.";
RL   Biochemistry 44:13491-13499(2005).
CC   -!- FUNCTION: Catalyzes the ATP-dependent amination of UTP to CTP with
CC       either L-glutamine or ammonia as the source of nitrogen. Regulates
CC       intracellular CTP levels through interactions with the four
CC       ribonucleotide triphosphates. {ECO:0000269|PubMed:11336655,
CC       ECO:0000269|PubMed:8385490, ECO:0000305|PubMed:15157079}.
CC   -!- CATALYTIC ACTIVITY: ATP + UTP + L-glutamine = ADP + phosphate +
CC       CTP + L-glutamate. {ECO:0000269|PubMed:11336655,
CC       ECO:0000269|PubMed:4550559, ECO:0000269|PubMed:8385490}.
CC   -!- ENZYME REGULATION: Allosterically activated by GTP, when glutamine
CC       is the substrate; GTP has no effect on the reaction when ammonia
CC       is the substrate (PubMed:4550559). The allosteric effector GTP
CC       functions by stabilizing the protein conformation that binds the
CC       tetrahedral intermediate(s) formed during glutamine hydrolysis
CC       (PubMed:11336655). Also activated by magnesium; the enzyme
CC       requires more Mg(2+) for full catalytic activity than required
CC       simply to complex the nucleotide substrates (PubMed:8385490).
CC       Inhibited by the product CTP, via allosteric rather than
CC       competitive inhibition (PubMed:8385490, PubMed:16216072). Also
CC       inhibited by divalent metal ions such as copper and zinc
CC       (PubMed:8385490). Is potently inhibited by the intermediate analog
CC       inhibitor glutamate gamma-semialdehyde (PubMed:11336655).
CC       {ECO:0000269|PubMed:11336655, ECO:0000269|PubMed:4550559,
CC       ECO:0000269|PubMed:8385490, ECO:0000305|PubMed:16216072}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.0 mM for ammonia {ECO:0000269|PubMed:11336655};
CC         KM=0.30 mM for L-glutamine (in the presence of 0.25 mM GTP)
CC         {ECO:0000269|PubMed:11336655};
CC         Note=kcat is 13 sec(-1) with ammonia as substrate. kcat is 6.6
CC         sec(-1) with L-glutamine as substrate (in the presence of 0.25
CC         mM GTP). {ECO:0000269|PubMed:11336655};
CC       pH dependence:
CC         Optimum pH is 8.7. {ECO:0000269|PubMed:8385490};
CC   -!- PATHWAY: Pyrimidine metabolism; CTP biosynthesis via de novo
CC       pathway; CTP from UDP: step 2/2. {ECO:0000255|HAMAP-
CC       Rule:MF_01227}.
CC   -!- SUBUNIT: Homodimer that associates to form homotetramer in the
CC       presence of ATP and UTP. The substrate nucleotides ATP and UTP act
CC       synergistically to promote oligomerization of CTPS from inactive
CC       dimers to active tetramers. {ECO:0000269|PubMed:4550560}.
CC   -!- DOMAIN: Sequence consists of two domains: the C-terminal glutamine
CC       amide transfer (GAT) domain catalyzes the hydrolysis of glutamine;
CC       the N-terminal synthase domain catalyzes the amination of UTP
CC       (PubMed:3514618, PubMed:3298209). Structure shows each subunit
CC       consists of three distinct segments: the N-terminal amidoligase
CC       (ALase) domain, which mediates oligomerization and contains the
CC       ALase active site where ATP and UTP substrates bind, and an
CC       interrupted helical interdomain linker segment that connects the
CC       ALase domain to the Type I glutamine amidotransferase (GATase) C-
CC       terminal domain, which generates ammonia via glutamine hydrolysis
CC       (PubMed:15157079). A gated channel that spans 25 Angstroms between
CC       the glutamine hydrolysis and amidoligase active sites provides a
CC       path for ammonia diffusion; the channel is accessible to solvent
CC       at the base of a cleft adjoining the glutamine hydrolysis active
CC       site, providing an entry point for exogenous ammonia
CC       (PubMed:15157079). {ECO:0000305|PubMed:15157079,
CC       ECO:0000305|PubMed:3298209, ECO:0000305|PubMed:3514618}.
CC   -!- MISCELLANEOUS: CTPSs have evolved a hybrid strategy for
CC       distinguishing between UTP and CTP. The overlapping regions of the
CC       product feedback inhibitory and substrate sites recognize a common
CC       feature in both compounds, the triphosphate moiety. To
CC       differentiate isosteric substrate and product pyrimidine rings, an
CC       additional pocket far from the expected kinase/ligase catalytic
CC       site, specifically recognizes the cytosine and ribose portions of
CC       the product inhibitor. {ECO:0000305|PubMed:16216072}.
CC   -!- SIMILARITY: Belongs to the CTP synthase family.
CC       {ECO:0000255|HAMAP-Rule:MF_01227}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M12843; AAA24485.1; -; mRNA.
DR   EMBL; U29580; AAA69290.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75822.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE76854.1; -; Genomic_DNA.
DR   PIR; H65059; SYECTP.
DR   RefSeq; NP_417260.1; NC_000913.3.
DR   RefSeq; WP_000210878.1; NZ_LN832404.1.
DR   PDB; 1S1M; X-ray; 2.30 A; A/B=1-545.
DR   PDB; 2AD5; X-ray; 2.80 A; A/B=1-545.
DR   PDBsum; 1S1M; -.
DR   PDBsum; 2AD5; -.
DR   ProteinModelPortal; P0A7E5; -.
DR   SMR; P0A7E5; -.
DR   DIP; DIP-10628N; -.
DR   IntAct; P0A7E5; 8.
DR   STRING; 511145.b2780; -.
DR   MEROPS; C26.964; -.
DR   SWISS-2DPAGE; P0A7E5; -.
DR   EPD; P0A7E5; -.
DR   PaxDb; P0A7E5; -.
DR   PRIDE; P0A7E5; -.
DR   EnsemblBacteria; AAC75822; AAC75822; b2780.
DR   EnsemblBacteria; BAE76854; BAE76854; BAE76854.
DR   GeneID; 946116; -.
DR   KEGG; ecj:JW2751; -.
DR   KEGG; eco:b2780; -.
DR   PATRIC; 32120976; VBIEscCol129921_2880.
DR   EchoBASE; EB0803; -.
DR   EcoGene; EG10810; pyrG.
DR   eggNOG; ENOG4105C8D; Bacteria.
DR   eggNOG; COG0504; LUCA.
DR   HOGENOM; HOG000077515; -.
DR   InParanoid; P0A7E5; -.
DR   KO; K01937; -.
DR   OMA; TMRLGEY; -.
DR   PhylomeDB; P0A7E5; -.
DR   BioCyc; EcoCyc:CTPSYN-MONOMER; -.
DR   BioCyc; MetaCyc:CTPSYN-MONOMER; -.
DR   BRENDA; 6.3.4.2; 2026.
DR   UniPathway; UPA00159; UER00277.
DR   EvolutionaryTrace; P0A7E5; -.
DR   PRO; PR:P0A7E5; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003883; F:CTP synthase activity; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IDA:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044210; P:'de novo' CTP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006241; P:CTP biosynthetic process; IDA:EcoCyc.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   CDD; cd01746; GATase1_CTP_Synthase; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   HAMAP; MF_01227; PyrG; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR004468; CTP_synthase.
DR   InterPro; IPR017456; CTP_synthase_N.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR033828; GATase1_CTP_Synthase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11550; PTHR11550; 1.
DR   Pfam; PF06418; CTP_synth_N; 1.
DR   Pfam; PF00117; GATase; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00337; PyrG; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome;
KW   Direct protein sequencing; Glutamine amidotransferase; Ligase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Pyrimidine biosynthesis;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:9298646}.
FT   CHAIN         2    545       CTP synthase.
FT                                /FTId=PRO_0000138183.
FT   DOMAIN      291    542       Glutamine amidotransferase type-1.
FT                                {ECO:0000255|HAMAP-Rule:MF_01227}.
FT   NP_BIND      15     20       ATP. {ECO:0000244|PDB:2AD5,
FT                                ECO:0000305|PubMed:16216072}.
FT   NP_BIND     147    149       Allosteric inhibitor CTP.
FT                                {ECO:0000244|PDB:2AD5,
FT                                ECO:0000305|PubMed:16216072}.
FT   NP_BIND     187    192       Allosteric inhibitor CTP; alternate.
FT                                {ECO:0000244|PDB:2AD5,
FT                                ECO:0000305|PubMed:16216072}.
FT   NP_BIND     187    192       UTP; alternate.
FT                                {ECO:0000305|PubMed:16216072}.
FT   NP_BIND     239    241       ATP. {ECO:0000244|PDB:2AD5,
FT                                ECO:0000305|PubMed:16216072}.
FT   REGION        2    266       Amidoligase domain.
FT                                {ECO:0000305|PubMed:15157079}.
FT   REGION      380    383       L-glutamine binding. {ECO:0000255|HAMAP-
FT                                Rule:MF_01227}.
FT   ACT_SITE    379    379       Nucleophile; for glutamine hydrolysis.
FT                                {ECO:0000305|PubMed:11336655,
FT                                ECO:0000305|PubMed:15157079}.
FT   ACT_SITE    515    515       {ECO:0000305|PubMed:15157079}.
FT   ACT_SITE    517    517       {ECO:0000305|PubMed:15157079}.
FT   METAL        72     72       Magnesium. {ECO:0000244|PDB:2AD5,
FT                                ECO:0000269|PubMed:16216072}.
FT   METAL       140    140       Magnesium. {ECO:0000244|PDB:2AD5,
FT                                ECO:0000269|PubMed:16216072}.
FT   BINDING      14     14       Allosteric inhibitor CTP; alternate.
FT                                {ECO:0000305|PubMed:16216072}.
FT   BINDING      14     14       UTP; alternate.
FT                                {ECO:0000305|PubMed:16216072}.
FT   BINDING      72     72       ATP. {ECO:0000244|PDB:2AD5,
FT                                ECO:0000305|PubMed:16216072}.
FT   BINDING     223    223       Allosteric inhibitor CTP; alternate.
FT                                {ECO:0000244|PDB:2AD5,
FT                                ECO:0000305|PubMed:16216072}.
FT   BINDING     223    223       UTP; alternate.
FT                                {ECO:0000305|PubMed:16216072}.
FT   BINDING     352    352       L-glutamine; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01227}.
FT   BINDING     403    403       L-glutamine. {ECO:0000255|HAMAP-
FT                                Rule:MF_01227}.
FT   BINDING     470    470       L-glutamine; via amide nitrogen.
FT                                {ECO:0000255|HAMAP-Rule:MF_01227}.
FT   MUTAGEN     349    349       V->S: 30% increase in both glutamine-
FT                                dependent and ammonia-dependent
FT                                activities. {ECO:0000269|PubMed:3298209}.
FT   MUTAGEN     352    352       G->P: Loss of glutamine-dependent
FT                                activity, but no change in ammonia-
FT                                dependent activity.
FT                                {ECO:0000269|PubMed:3298209}.
FT   MUTAGEN     379    379       C->A,S: Loss of glutamine-dependent
FT                                activity, but no change in ammonia-
FT                                dependent activity.
FT                                {ECO:0000269|PubMed:11336655}.
FT   CONFLICT    338    338       V -> L (in Ref. 1; AAA24485).
FT                                {ECO:0000305}.
FT   CONFLICT    476    476       M -> S (in Ref. 1; AAA24485).
FT                                {ECO:0000305}.
FT   STRAND        4     10       {ECO:0000244|PDB:1S1M}.
FT   STRAND       12     14       {ECO:0000244|PDB:1S1M}.
FT   HELIX        18     30       {ECO:0000244|PDB:1S1M}.
FT   TURN         31     33       {ECO:0000244|PDB:1S1M}.
FT   STRAND       36     42       {ECO:0000244|PDB:1S1M}.
FT   HELIX        49     51       {ECO:0000244|PDB:1S1M}.
FT   TURN         54     56       {ECO:0000244|PDB:1S1M}.
FT   STRAND       60     62       {ECO:0000244|PDB:2AD5}.
FT   STRAND       68     70       {ECO:0000244|PDB:2AD5}.
FT   HELIX        72     79       {ECO:0000244|PDB:1S1M}.
FT   HELIX        86     88       {ECO:0000244|PDB:1S1M}.
FT   STRAND       89     91       {ECO:0000244|PDB:1S1M}.
FT   HELIX        92    104       {ECO:0000244|PDB:1S1M}.
FT   TURN        105    110       {ECO:0000244|PDB:1S1M}.
FT   HELIX       115    131       {ECO:0000244|PDB:1S1M}.
FT   STRAND      135    141       {ECO:0000244|PDB:1S1M}.
FT   HELIX       148    150       {ECO:0000244|PDB:2AD5}.
FT   HELIX       151    164       {ECO:0000244|PDB:1S1M}.
FT   STRAND      168    176       {ECO:0000244|PDB:1S1M}.
FT   TURN        181    184       {ECO:0000244|PDB:1S1M}.
FT   HELIX       189    199       {ECO:0000244|PDB:1S1M}.
FT   TURN        200    202       {ECO:0000244|PDB:1S1M}.
FT   STRAND      206    214       {ECO:0000244|PDB:1S1M}.
FT   HELIX       218    226       {ECO:0000244|PDB:1S1M}.
FT   HELIX       232    234       {ECO:0000244|PDB:2AD5}.
FT   STRAND      235    239       {ECO:0000244|PDB:1S1M}.
FT   HELIX       244    246       {ECO:0000244|PDB:1S1M}.
FT   HELIX       247    253       {ECO:0000244|PDB:1S1M}.
FT   HELIX       256    263       {ECO:0000244|PDB:1S1M}.
FT   HELIX       274    284       {ECO:0000244|PDB:1S1M}.
FT   STRAND      287    298       {ECO:0000244|PDB:1S1M}.
FT   HELIX       302    305       {ECO:0000244|PDB:1S1M}.
FT   HELIX       306    318       {ECO:0000244|PDB:1S1M}.
FT   STRAND      321    329       {ECO:0000244|PDB:1S1M}.
FT   HELIX       330    336       {ECO:0000244|PDB:1S1M}.
FT   TURN        338    343       {ECO:0000244|PDB:1S1M}.
FT   STRAND      345    349       {ECO:0000244|PDB:1S1M}.
FT   HELIX       358    370       {ECO:0000244|PDB:1S1M}.
FT   STRAND      375    378       {ECO:0000244|PDB:1S1M}.
FT   HELIX       380    394       {ECO:0000244|PDB:1S1M}.
FT   TURN        402    404       {ECO:0000244|PDB:1S1M}.
FT   STRAND      411    414       {ECO:0000244|PDB:1S1M}.
FT   TURN        416    418       {ECO:0000244|PDB:1S1M}.
FT   STRAND      440    448       {ECO:0000244|PDB:1S1M}.
FT   HELIX       453    457       {ECO:0000244|PDB:1S1M}.
FT   STRAND      460    469       {ECO:0000244|PDB:1S1M}.
FT   HELIX       475    483       {ECO:0000244|PDB:1S1M}.
FT   STRAND      487    491       {ECO:0000244|PDB:1S1M}.
FT   STRAND      493    495       {ECO:0000244|PDB:1S1M}.
FT   STRAND      498    502       {ECO:0000244|PDB:1S1M}.
FT   STRAND      506    514       {ECO:0000244|PDB:1S1M}.
FT   HELIX       516    518       {ECO:0000244|PDB:1S1M}.
FT   TURN        522    524       {ECO:0000244|PDB:1S1M}.
FT   HELIX       527    542       {ECO:0000244|PDB:1S1M}.
SQ   SEQUENCE   545 AA;  60374 MW;  FBB9E2E18FA355FC CRC64;
     MTTNYIFVTG GVVSSLGKGI AAASLAAILE ARGLNVTIMK LDPYINVDPG TMSPIQHGEV
     FVTEDGAETD LDLGHYERFI RTKMSRRNNF TTGRIYSDVL RKERRGDYLG ATVQVIPHIT
     NAIKERVLEG GEGHDVVLVE IGGTVGDIES LPFLEAIRQM AVEIGREHTL FMHLTLVPYM
     AASGEVKTKP TQHSVKELLS IGIQPDILIC RSDRAVPANE RAKIALFCNV PEKAVISLKD
     VDSIYKIPGL LKSQGLDDYI CKRFSLNCPE ANLSEWEQVI FEEANPVSEV TIGMVGKYIE
     LPDAYKSVIE ALKHGGLKNR VSVNIKLIDS QDVETRGVEI LKGLDAILVP GGFGYRGVEG
     MITTARFARE NNIPYLGICL GMQVALIDYA RHVANMENAN STEFVPDCKY PVVALITEWR
     DENGNVEVRS EKSDLGGTMR LGAQQCQLVD DSLVRQLYNA PTIVERHRHR YEVNNMLLKQ
     IEDAGLRVAG RSGDDQLVEI IEVPNHPWFV ACQFHPEFTS TPRDGHPLFA GFVKAASEFQ
     KRQAK
//
